Euclidean Capital LLC 13D and 13G filings for PMV Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:05 pm Purchase | 2026-03-31 | 13G | PMV PHARMACEUTICALS INC PMVP | Euclidean Capital LLC | 2,627,643 4.900% | 290,734 (+12.44%) | Filing |
| 2022-02-14 07:17 am Sale | 2021-12-31 | 13G | PMV PHARMACEUTICALS INC PMVP | Euclidean Capital LLC | 2,336,909 5.100% | -118,290 (-4.82%) | Filing |
| 2021-10-18 3:50 pm Sale | 2021-10-15 | 13G | PMV PHARMACEUTICALS INC PMVP | Euclidean Capital LLC | 2,455,199 5.400% | -2,218,624 (-47.47%) | Filing |